Selective anti-CXCR2 receptor blockade by AZD5069 inhibits CXCL8-mediated pro-tumorigenic activity in human thyroid cancer cells in vitro
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Endocrinological Investigation"
DOI: 10.1007/s40618-024-02410-6
Abstract: Thyroid cancer is the most common endocrine malignancy. Current therapies are successful, however some patients progress to therapeutically refractive disease. The immunotherapeutic potential of the CXCL8-chemokine/CXCR2-chemokine-receptor system is currently being explored in numerous human cancers.… read more here.
Keywords: cancer; cxcl8 mediated; cxcr2; thyroid cancer ... See more keywords